Zobrazeno 1 - 10
of 70
pro vyhledávání: '"V. V. Kukhar"'
Autor:
G. P. Arutyunov, S. A. Boytsov, M. I. Voevoda, O. M. Drapkina, V. V. Kukharchuk, A. I. Martynov, M. V. Shestakova, V. S. Gurevich, I. V. Sergienko, A. S. Alieva, N. M. Akhmedzhanov, M. G. Bubnova, A. S. Galyavich, I. G. Gordeev, M. V. Yezhov, Yu. A. Karpov, V. O. Konstantinov, S. V. Nedogoda, E. M. Nifontov, Y. A. Orlova, A. V. Panov, S. A. Saiganov, V. V. Skibitsky, E. I. Tarlovskaya, S. A. Urazgildeeva, Yu. Sh. Khalimov
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 9, Pp 44-51 (2019)
In opinion the Expert council provides management tactics for patients with hypertriglyceridemia (HTG). It is demonstrated that HTG is a common condition in overweight patients and is an important component of residual risk. HTG creates additional co
Externí odkaz:
https://doaj.org/article/1eaf4fd217b84091ba3e9c5568297eeb
Autor:
V. C. Moiseev, N. A. Mukhin, A. V. Smirnov, J. D. Kobalava, I. N. Bobkova, S. V. Villevalde, M. A. Yefremovtseva, L. V. Kozlovskaya, M. Yu. Shvetsov, M. V. Shestakova, G. P. Arutyunov, S. A. Boytsov, A. S. Galyavich, Y. I. Greenstein, V. A. Dobronravov, O. M. Drapkina, V. M. Ermolenko, Yu. A. Karpov, I. G. Kayukov, J. V. Kotovsky, V. V. Kukharchuk, A. I. Martynov, T. E. Morozova, R. G. Oganov, V. I. Podzolkov, L. Ya. Rozhinskaya, S. N. Tereshchenko, V. V. Fomin, V. N. Khirmanov, I. E. Chazova, M. Sh. Shamkhalova, E. M. Shilov, E. V. Shlyakhto, A. M. Shutov
Publikováno v:
Российский кардиологический журнал, Vol 0, Iss 8, Pp 7-37 (2014)
Externí odkaz:
https://doaj.org/article/d1bd210a3de646beb2e4bd0da7c2ac53
Autor:
A. Catapano, E. V. Shlyakhto, A. I. Martynov, R. G. Oganov, V. V. Kukharchuk, M. V. Shestakova, A. S. Ametov, S. A. Boicov, M. G. Bubnova, S. V. Villevalde, A. S. Galyavich, Yu. A. Karpov, J. D. Kobalava, O. N. Koziolova
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 12, Iss 4, Pp 75-78 (2013)
Expert Consensus. Role of combination lipid-lowering therapy (simvastatin/ezetimibe 20/10 mg) in the correction of lipid metabolism disturbances in patients with chronic kidney disease.
Externí odkaz:
https://doaj.org/article/16dc7004b2a04aecb190a64ca269eadf
Autor:
R. G. Oganov, V. V. Kukharchuk, G. P. Arutyunov, A. S. Galyavich, V. S. Gurevich, D. V. Duplyakov, Yu. A. Karpov, Zh. D. Kobalava, V. O. Konstantinov, S. Yu. Martsevich, A. V. Panov, I. V. Sergienko, V. V. Skibitskyi, O. G. Smolenskaya, A. V. Susekov, V. P. Tyurin, S. V. Shalaev, O. A. Maneshina, O. V. Brigida
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 11, Iss 4, Pp 70-78 (2012)
The high prevalence of persistent dyslipidemia in primary and specialized care patients treated with statins justifies the need to identify its reasons and develop the recommendations on the treatment optimization. At present, Russian studies focusin
Externí odkaz:
https://doaj.org/article/adb01c6a0e7448e393385e98a5bf77e0
Autor:
S. A. Boytsov, V. V. Kukharchuk, Yu. A. Karpov, I. V. Sergienko, O. M. Drapkina, A. E. Semenova, S. Zh. Urazalina
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 11, Iss 3, Pp 82-86 (2012)
Subclinical atherosclerosis is an initial, latent stage of chronic progressing arterial inflammation. Destabilisation of asymptomatic, hemodynamically non-significant atherosclerotic plaques (AP) could lead to myocardial infarction, stroke, or sudden
Externí odkaz:
https://doaj.org/article/d165f5f6d5e648029aa4a35e04dfe50c
Autor:
S. Sh. Urazalina, A. N. Rogoza, T. V. Balakhonova, R. P. Myasnikov, T. E. Kolmakova, Yu. A. Karpov, V. V. Kukharchuk, S. A. Boytsov
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 10, Iss 4, Pp 14-20 (2011)
Aim. To assess the degree of cardiovascular (CV) risk adjustment in patients with low and intermediate risk by the SCORE scale, who were further examined in accordance with the European Society of Hypertension/European Society of Cardiology Guideline
Externí odkaz:
https://doaj.org/article/d7c29f8d9f564da790e5a3d52dd60341
Autor:
G. F. Piksina, Yu. A. Shuvalova, V. I. Kaminnaya, Yu. V. Dotsenko, V. N. Titov, V. V. Kukharchuk, A. I. Kaminny
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 9, Iss 5, Pp 37-40 (2010)
Aim. To study the effects of the combined therapy with atorvastatin and polyunsaturated omega-3 fatty acids (omega-3 PUFA) on lipid profile, lipoprotein-associated phospholipase A2 (Lp-PLA (2)), and thromboxane B2. Material and methods. The study inc
Externí odkaz:
https://doaj.org/article/7777393221e94b96b1794a1ec103466f
Autor:
M. S. Safarova, M. V. Ezhov, V. P. Lupanov, I. A. Alekseeva, Yu. G. Matchin, V. V. Kukharchuk
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 9, Iss 5, Pp 86-90 (2010)
Externí odkaz:
https://doaj.org/article/dfde505e39244c24af3dd1ad8a849816
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 8, Iss 6, Pp 16-20 (2009)
Aim. To assess lipid-lowering effectiveness of generic atorvastatin in patients with various hyperlipidaemia (HLP) phenotypes in an open, short-term (four weeks) study.Material and methods. All participants were divided into two groups — with isola
Externí odkaz:
https://doaj.org/article/195c4bdf77ae40de9af8b7ccc345bc95
Autor:
I. V. Sergienko, A. E. Semenova, V. V. Masenko, S. A. Gabrusenko, V. V. Kukharchuk, Yu. N. Belenkov
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 8, Iss 5, Pp 22-27 (2009)
Aim. To investigate the effects of different doses of statins on the levels of factors stimulating and inhibiting coronary angiogenesis.Material and methods. The study included 90 patients with coronary heart disease (CHD), Functional Class I-III sta
Externí odkaz:
https://doaj.org/article/58532b88eeb94b7da938fa1437a30c62